Nuo Therapeutics, Inc. (AURX) stock

AURXOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/30

$1.26−0.04 (-3.08%)

Close on Oct 19, 2026Market cap $61.08MP/E –Yield –

Nuo Therapeutics price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Nuo Therapeutics's price to sales ratio was 11.7× on Oct 19, 2026, against 48.0× a year earlier. Over the last 5 years it ranged from 1.5× to 376.8×, with a median of 34.0×.

Price to Sales Ratio at the end of each year

Period	Period end	Value	Change (pts)
2026	Oct 19, 2026	11.7×	−24.4
2025	Dec 31, 2025	36.1×	−19.8
2024	Dec 31, 2024	55.9×	+8.0
2023	Dec 29, 2023	47.9×	+20.9
2020	Oct 30, 2020	27.0×	+24.0
2019	Dec 31, 2019	3.0×	+1.7
2018	Dec 31, 2018	1.3×	–

Where these numbers come from

Parsed from the XBRL in Nuo Therapeutics's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing